Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Montemuiño S, Dios NR, Martín M, Taboada B, Calvo-Crespo P, Samper-Ots MP, López-Guerra JL, López-Mata M, Jové-Teixidó J, Díaz-Díaz V, Ingunza-Barón L, Murcia-Mejía M, Chust M, García-Cañibano T, Couselo ML, Puertas MM, Cerro ED, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Couñago F. Montemuiño S, et al. Among authors: dios nr. Rep Pract Oncol Radiother. 2020 May-Jun;25(3):447-455. doi: 10.1016/j.rpor.2020.03.006. Epub 2020 Mar 18. Rep Pract Oncol Radiother. 2020. PMID: 32477011 Free PMC article.
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F, Montemuiño S, Martin M, Taboada B, Calvo-Crespo P, Samper-Ots MP, Alcántara P, Corona J, López-Guerra JL, Murcia-Mejía M, López-Mata M, Jové-Teixidó J, Chust M, Díaz-Díaz V, de Ingunza-Barón L, García-Cañibano T, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Puertas MM, Thuissard IJ, Sanz-Rosa D, de Dios NR. Couñago F, et al. Among authors: de dios nr. Clin Transl Oncol. 2019 Jun;21(6):735-744. doi: 10.1007/s12094-018-1976-3. Epub 2018 Nov 14. Clin Transl Oncol. 2019. PMID: 30430394
Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav.
Couñago F, de Dios NR, Montemuiño S, Jové-Teixidó J, Martin M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, Díaz-Díaz V, de Ingunza-Barón L, Murcia-Mejía M, Alcántara P, Corona J, Puertas MM, Chust M, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Taboada B. Couñago F, et al. Among authors: de dios nr. Lung Cancer. 2018 Sep;123:174-175. doi: 10.1016/j.lungcan.2018.06.031. Epub 2018 Jul 13. Lung Cancer. 2018. PMID: 30017426 No abstract available.
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Warner A, Dahele M, Hu B, Palma DA, Senan S, Oberije C, Tsujino K, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris L, Ramella S, De Ruyck K, De Dios NR, Bradley JD, Rodrigues G. Warner A, et al. Among authors: de dios nr. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):612-20. doi: 10.1016/j.ijrobp.2015.11.030. Epub 2015 Nov 23. Int J Radiat Oncol Biol Phys. 2016. PMID: 26867890
Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
Rodrigues G, Oberije C, Senan S, Tsujino K, Wiersma T, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris L, Ramella S, DeRuyck K, De Dios NR, Warner A, Bradley JD, Palma DA. Rodrigues G, et al. Among authors: de dios nr. Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):133-9. doi: 10.1016/j.ijrobp.2014.09.033. Int J Radiat Oncol Biol Phys. 2015. PMID: 25835622 Clinical Trial.
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.
Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, Barriger RB, Moreno-Jiménez M, Kim TH, Ramella S, Everitt S, Rengan R, Marks LB, De Ruyck K, Warner A, Rodrigues G. Palma DA, et al. Among authors: de dios nr. Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):690-6. doi: 10.1016/j.ijrobp.2013.07.029. Epub 2013 Sep 10. Int J Radiat Oncol Biol Phys. 2013. PMID: 24035329 Review.
14 results